Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Transplant Proc ; 49(1): 163-166, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28104127

RESUMEN

BACKGROUND: Calcineurin-inhibitor-induced pain syndrome (CIPS) was used as a reference in the literature as reflex sympathetic dystrophy syndrome related to calcineurin inhibitors. Much of the literature describes CIPS that occurred after kidney and bone marrow transplantation. We describe a rare case of CIPS in induction immunosuppression before kidney transplantation, under administration of an anti-rheumatoid drug. METHODS: A 53-year-old woman had pre-status of ABO-incompatible living kidney transplantation. The patient had rheumatoid arthritis, but that was well-controlled with salazosulfapyridine as an anti-rheumatoid drug. Fourteen days before transplantation, she received induction immunosuppressive therapy consisting of tacrolimus (TAC) and mycophenolate mofetil (MMF) and she stopped taking salazosulfapyridine. The third day after that treatment, she had a high fever, fatigue, and joint pains of the knees, elbows, and wrists. RESULTS: When the patient stopped taking TAC and MMF and started taking salazosulfapyridine again, she soon recovered. Next, we challenged same induction immunosuppression therapy with administration of salazosulfapyridine; however, the patient had the same symptom. We considered that the symptom was caused by TAC or MMF, and we did not challenge-test each drug. We found that taking only TAC caused the same symptom for the patient. Also, we challenged cyclosporine (CsA) with MMF and confirmed that she did not have the symptom. CONCLUSIONS: We decided that drugs of the induction immunosuppression therapy were CsA, MMF, prednisolone, and basiliximab. The patient received induction therapy with plasmapheresis and rituximab in addition to the above-mentioned drugs, and we performed ABO-incompatible kidney transplantation for her. The post-surgical course was good, without acute rejection, and she had no pain.


Asunto(s)
Artralgia/inducido químicamente , Inhibidores de la Calcineurina/efectos adversos , Rechazo de Injerto/prevención & control , Inmunosupresores/uso terapéutico , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Tacrolimus/efectos adversos , Anticuerpos Monoclonales/uso terapéutico , Antirreumáticos/uso terapéutico , Artritis Reumatoide/complicaciones , Artritis Reumatoide/tratamiento farmacológico , Basiliximab , Incompatibilidad de Grupos Sanguíneos , Ciclosporina/uso terapéutico , Femenino , Supervivencia de Injerto , Humanos , Factores Inmunológicos/uso terapéutico , Fallo Renal Crónico/complicaciones , Persona de Mediana Edad , Ácido Micofenólico/uso terapéutico , Plasmaféresis , Cuidados Preoperatorios , Proteínas Recombinantes de Fusión/uso terapéutico , Rituximab/uso terapéutico , Sulfasalazina/uso terapéutico
2.
Aktuelle Urol ; 45(2): 132-4, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24700069

RESUMEN

A 48-year-old male presented with para-aortic lymph node metastases after surgical resection of a clear cell renal cell carcinoma. After first-line treatment with interferon alpha-2b, he was started on pazopanib and lapatinib. Blood pressure was well controlled with temocapril and amlodipine. Treatment had to be stopped 4 years and 8 months after initiation due to overt proteinuria. Then, sunitinib was started as third-line treatment. During the second cycle of sunitinib, he died due to a Stanford type A aortic dissection. Acute aortic dissection could be an adverse event associated with the long-term use of antiangiogenic tyrosine kinase inhibitors.


Asunto(s)
Inhibidores de la Angiogénesis/efectos adversos , Aneurisma de la Aorta/inducido químicamente , Aneurisma de la Aorta/patología , Disección Aórtica/inducido químicamente , Disección Aórtica/patología , Carcinoma de Células Renales/tratamiento farmacológico , Indoles/efectos adversos , Neoplasias Renales/tratamiento farmacológico , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Pirroles/efectos adversos , Enfermedad Aguda , Inhibidores de la Angiogénesis/administración & dosificación , Carcinoma de Células Renales/patología , Quimioterapia Adyuvante , Resultado Fatal , Humanos , Indoles/administración & dosificación , Neoplasias Renales/patología , Cuidados a Largo Plazo , Metástasis Linfática/patología , Masculino , Persona de Mediana Edad , Proteínas Tirosina Quinasas/administración & dosificación , Pirroles/administración & dosificación , Sunitinib , Tomografía Computarizada por Rayos X
4.
Aktuelle Urol ; 40(4): 247-9, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19294616

RESUMEN

A 42-year-old female presented with right back pain. The CT scan revealed a 72-mm space-occupying lesion in the middle portion of the right kidney. No metastasis was proven. She underwent laparoscopic radical nephrectomy and lymph node disection. The histopathological examination revealed a high-grade primitive small round tumor the cells of which were strongly positive for CD99 and vimentin. Fluorescence in situ hybridization analysis using a DNA probe for the Ewing sarcoma breakpoint region 1 (EWSR 1) on chromosome 22g12 revealed a rearrangement of the EWSR 1 locus. The diagnosis was Ewing's sarcoma / primitive neuroectodermal tumor of the kidney. She underwent 13 cycles of chemotherapy, and has no evidence of recurrence 19 months after surgery.


Asunto(s)
Neoplasias Renales/diagnóstico , Tumores Neuroectodérmicos Primitivos/diagnóstico , Sarcoma de Ewing/diagnóstico , Adulto , Biomarcadores de Tumor/genética , Proteínas de Unión a Calmodulina/genética , Quimioterapia Adyuvante , Cromosomas Humanos Par 22/genética , Terapia Combinada , Diagnóstico Diferencial , Supervivencia sin Enfermedad , Femenino , Reordenamiento Génico/genética , Humanos , Hibridación Fluorescente in Situ , Riñón/patología , Neoplasias Renales/patología , Neoplasias Renales/cirugía , Laparoscopía , Escisión del Ganglio Linfático , Nefrectomía , Tumores Neuroectodérmicos Primitivos/tratamiento farmacológico , Tumores Neuroectodérmicos Primitivos/patología , Tumores Neuroectodérmicos Primitivos/cirugía , Proteína EWS de Unión a ARN , Proteínas de Unión al ARN/genética , Cintigrafía , Sarcoma de Ewing/tratamiento farmacológico , Sarcoma de Ewing/patología , Sarcoma de Ewing/cirugía , Tomografía Computarizada por Rayos X
5.
Plant Cell Physiol ; 42(4): 385-94, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11333309

RESUMEN

Certain mutants of shoot gravitropism were reported to be ascribed to the SCR and SHR loci in Arabidopsis thaliana. The SCR gene was known to regulate the development of endodermis cells that are responsible for sensing gravity in a shoot. With the aim of elucidating the molecular mechanism for gravitropic responses in pea seedlings, we have isolated a putative pea SCR ortholog from a shoot cDNA library. Analyses of the cDNA clones revealed the structure of a full-length ORF coding for 819 amino acid residues. A remarkable feature of pea SCR protein was the presence of asparagine stretches at the N-terminal transcriptional activation domain, which was distinct from the occurrence of glutamine or alanine stretches in the Arabidopsis or maize SCR. A Northern blot analysis revealed a single 3.2-kb pea SCR transcript in addition to a closely related 2.5-kb transcript. Our in situ hybridization data indicated that pea SCR mRNA accumulated in the shoot apical meristem, leaf primordia and a root single cell layer corresponding to the endodermis. The expression patterns were similar to those reported for A. thaliana and Zea mays, suggesting that SCR may be functionally conserved among plants and involved in the differentiation of the endodermis.


Asunto(s)
Proteínas de Arabidopsis , Regulación de la Expresión Génica de las Plantas , Pisum sativum/genética , Proteínas de Plantas/genética , Secuencia de Aminoácidos , Arabidopsis/genética , Evolución Biológica , Clonación Molecular , Secuencia Conservada , Cartilla de ADN , Biblioteca de Genes , Variación Genética , Leucina Zippers , Datos de Secuencia Molecular , Pisum sativum/clasificación , Brotes de la Planta/fisiología , Alineación de Secuencia , Homología de Secuencia de Aminoácido
6.
Adv Space Res ; 23(12): 2017-20, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-11710384

RESUMEN

Stem growth of Prunus trees under simulated microgravity conditions was examined using a three-dimensional clinostat. The stems elongated with bending under such conditions. Stem elongation and leaf expansion were both promoted, whereas the formation of xylem in the secondary thickening growth was inhibited under the simulated microgravity condition. In secondary xylem, sedimentable amyloplasts were observed in the 1g control. The present results suggest that stem elongation and leaf expansion may be inhibited at 1g, while growth direction and secondary xylem formation depend on a gravity stimulus. A space experiment is expected to advance research on thickening growth in trees. Grant Numbers: 07456073, 1D 215.


Asunto(s)
Tallos de la Planta/crecimiento & desarrollo , Plastidios/fisiología , Prunus/crecimiento & desarrollo , Simulación de Ingravidez , Gravitación , Hojas de la Planta/crecimiento & desarrollo , Hojas de la Planta/ultraestructura , Tallos de la Planta/ultraestructura , Prunus/ultraestructura , Rotación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA